Delcath Systems Inc
NASDAQ:DCTH
| Market Cap (Intraday) | 391.79M |
| Current PE | N/A |
| Forward PE | 375 |
| 2yr Forward PE | 17.86 |
| 10-Day MA | $11.78 |
| 50-Day MA | $14.55 |
| 200-Day MA | $12.78 |
Delcath Systems Inc Stock, NASDAQ:DCTH
566 Queensbury Avenue, Suite 22C, Queensbury, New York 12804
United States of America
Phone: +1.212.489.2100
Number of Employees: 96
Description
Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.